Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Total Current Liabilities (2016 - 2025)

Avanos Medical (AVNS) has disclosed Total Current Liabilities for 13 consecutive years, with $165.2 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities changed 0.42% to $165.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165.2 million through Dec 2025, changed 0.42% year-over-year, with the annual reading at $165.2 million for FY2025, 0.42% changed from the prior year.
  • Total Current Liabilities hit $165.2 million in Q4 2025 for Avanos Medical, up from $147.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $234.6 million in Q4 2023 to a low of $129.2 million in Q3 2021.
  • Historically, Total Current Liabilities has averaged $167.0 million across 5 years, with a median of $159.5 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 37.21% in 2022 and later plummeted 35.35% in 2025.
  • Year by year, Total Current Liabilities stood at $139.2 million in 2021, then skyrocketed by 37.21% to $191.0 million in 2022, then grew by 22.83% to $234.6 million in 2023, then fell by 29.28% to $165.9 million in 2024, then decreased by 0.42% to $165.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for AVNS at $165.2 million in Q4 2025, $147.9 million in Q3 2025, and $134.6 million in Q2 2025.